Franck Auvray joins BlueReg Group as Vice President and General Manager of Pharma Blue

2 January 2018


Sophia-Antipolis (France) - January 2, 2018 – BlueReg Group announced today that Franck Auvray has been appointed Vice President and General Manager of Pharma Blue. In this role Franck Auvray assumes direct responsibility to drive the overall Pharma Blue strategy and growth in France, as well as develop the EU ambition of the company.


“Pharma Blue is a fast-growing French company who partners with international and innovative biopharmaceutical industry for fast market access today in France and tomorrow in main European countries. I am very excited to lead this organization into the next phase of its development,” said Mr. Auvray.


Franck Auvray has more than 25 years’ experience in the pharmaceutical industry. He joins BlueReg/Pharma Blue from Celgene, where, as General Manager of Celgene France, he managed a fast-growing specialty care business for the treatment of cancer and other severe, immune, inflammatory conditions. During 10 years at Celgene, Franck built a strong track record, delivering solid business results and developing a successful and robust organization. Before joining Celgene, Franck Auvray spent 18 years at Roche pharmaceuticals. During this time, he held various positions of increasing responsibility.


As Vice President and General Manager of Pharma Blue, Franck Auvray will report to Corinne Schmitz, CEO of BlueReg Group. “Franck’s extensive pharmaceutical specialty care experience and proven leadership skills will help me to take our successful operations to the next level, pursuing our rapid expansion,” said Corinne Schmitz.


- Ends -


About BlueReg Group & Pharma Blue

BlueReg is a privately owned, international consultancy organization, located in Europe (France, UK) and in the US. BlueReg offers strategic advice and hands-on outsourcing solutions to life sciences companies through the entire lifecycle of their products (from product development, registration through to launch and product maintenance).

For more information, visit


Pharma Blue is a subsidiary of BlueReg, located in France, who partners with Pharmaceutical companies for the launch of their products on the French market. Having obtained a specific “Exploitant” authorisation from the French Medicines Agency (ANSM), Pharma Blue provides flexible cost-effective solutions and delivers market opportunities for specialty, rare disease, biotech, and innovative healthcare organizations. For more information, visit

For further information,


Did you like this article? Share on social networks:

Discover our last white Paper

Learn more